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Abstract Monoclonal antibody MPM-2 recognizes a large 
family of mitotic phosphoproteins in a phosphorylation-depend-
ent manner. The antigenic phosphoepitope, designated the 
MPM-2 epitope, putatively consists of hydrophobic residue-
Thr/Ser-Pro-hydrophobic residue-uncharged/basic residue. In 
this study, we addressed whether this sequence motif contains 
all the information necessary for recognition and phosphoryla-
tion by the kinase that phosphorylates most MPM-2 antigens. A 
fusion protein between glutathione S-transferase and a 19-
residue peptide that contained two representative MPM-2 
epitope sequences overlapping with two potential MAP kinase 
phosphorylation sites was constructed. Both the MPM-2 epitope 
sequences in the fusion protein (GST-MPM2) were phosphory-
lated by Xenopus egg extract, making the fusion protein MPM-2 
reactive. However, while MAP kinase phosphorylated both the 
MPM-2 epitope sequences, neither ME kinase-H, a good 
candidate for a major MPM-2 epitope kinase, nor mitotic cdc2 
kinase, which is known to phosphorylate certain MPM-2 
antigens in vitro, phosphorylated GST-MPM2 to any significant 
extent. Furthermore, depletion of MAP kinase activity removed 
most, if not all, of the GST-MPM2 phosphorylating activity 
from crude Xenopus egg extracts. These results suggest that 
additional or different structural information than that provided 
by the deduced MPM-2 epitope sequence is required for 
recognition and phosphorylation by ME kinase-H or other 
major MPM-2 epitope kinases. They also offer a valid 
explanation for selective phosphorylation of certain MPM-2 
antigens by MAP kinase as well as selective recognition of 
certain phosphorylated MAP kinase substrates by MPM-2. 
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1. Introduction 
The entry of eukaryotic cells into M phase is accompanied 
by a dramatic increase in the level of protein phosphorylation 
[1-3], which plays a dominant role in the induction of various 
mitotic events. For mitotic phosphorylation to occur, multiple 
mitotic kinases must be activated in a coordinated manner at 
entry into mitosis. Each kinase then phosphorylates a specific 
family of mitotic phosphoproteins, which in turn participates 
in the induction of a specific set of mitotic events. 
While many mitotic kinases have been identified, character-
ization of their in vivo substrates has been difficult owing to 
the lack of specific probes or assays. One exception is the 
MPM-2 antigens, the family of mitotic phosphoproteins rec-
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ognized by the phosphoepitope monoclonal antibody MPM-2 
[4]. MPM-2 antigens include regulators of mitotic cdc2 kinase, 
cdc25 phosphatase, weel kinase, and mytl kinase [5-7]; M 
phase-promoting kinase nimA [8]; casein kinase II [9], which 
is also implicated in the G2/M transition [10]; structural pro-
teins of the mitotic apparatus, MAP4 [11], topoisomerase II a 
[12], and INCEMP [13]; ubiquitin-conjugating enzyme APC, 
which is required for anaphase onset [14]; and several proteins 
associated with transcription or translation [9,13]. However, 
the identity of the physiological kinase that phosphorylates 
most MPM-2 antigens remains to be established. 
Since MPM-2 is a monoclonal antibody, MPM-2 antigens 
are likely to contain a common phosphorylation site that is 
phosphorylated by common or similar kinases. By screening 
of a phage peptide display library, it was deduced that the 
MPM-2 epitope sequence consists of a string of five amino 
acids, with LTPLK being the most frequent amino acids at 
each position [15]. When the cloned MPM-2 antigens MPP1 
and MPP2 were examined, multiple LTPLK-related sequences 
were found, among which at least FTPLQ was sufficient to 
confer MPM-2 reactivity. Finally, while both FTPLQ and 
LTPLK peptides were readily phosphorylated by mitotic kin-
ases, FTPLQ exhibited a much higher binding affinity for 
MPM-2 than LTPLK. This suggests that a basic amino acid 
at the fifth position is tolerated but not preferred by the 
MPM-2 epitope sequence. It was also found that KTPVK 
exhibited no MPM-2 binding affinity upon phosphorylation, 
suggesting that a basic amino acid at the first position is not 
tolerated by the MPM-2 epitope sequence. In summary, it 
appears that a preferred MPM-2 epitope sequence contains 
hydrophobic residue-Thr/Ser-Pro-hydrophobic residue-un-
charged residue. 
Based on the deduced MPM-2 epitope sequence, several 
predictions can be made about the kinase that phosphorylates 
MPM-2 antigens, designated MPM-2 epitope kinase or ME 
kinase. First, the ME kinase should be a proline-directed ser-
ine/threonine protein kinase and thus most of the identified M 
phase-promoting protein kinases are not likely candidates. 
Second, mitotic cdc2 kinase, which is proline-directed, should 
be able to phosphorylate some but not all MPM-2 antigens 
since LTPLK but not FTPLQ satisfies S/T-P-X-(K/R), the 
phosphorylation consensus for mitotic cdc2 kinase [16]. This 
prediction is consistent with the results from several in vitro 
studies [7,8,13,15,17,18]. Third, the most preferred substrates 
of miotic cdc2 kinase are probably not MPM-2 antigens since 
the strongest phosphorylation sites for cdc2 kinase often con-
tain two or three basic amino acids [19,20]. This has been 
confirmed by the finding that the most commonly used in 
vitro substrate of cdc2 kinase, histone HI, is not recognized 
by MPM-2 upon mitotic phosphorylation [4]. Based on these 
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analyses, it appears that the MPM-2 epitope does not repre-
sent the phosphorylation consensus sequence for mitotic cdc2 
kinase or any other characterized mitotic kinase. 
To identify the MPM-2 epitope kinase, we developed an in 
situ ME kinase assay, with which we found two kinase activ-
ities in Xenopus egg extract that phosphorylate the MPM-2 
epitope: the 42-kDa MAP kinase that phosphorylated a single 
polypeptide of approximately 150 kDa, and the &670-kDa 
ME kinase-H that generated MPM-2 reactivity on multiple 
polypeptides [18]. Mitotic cdc2 kinase did not exhibit ME 
kinase activity with this assay. Since ME kinase-H was the 
only prominent activity detected that phosphorylated the 
MPM-2 epitope on multiple polypeptides and did not seem 
to be related to any of the identified mitotic kinases, we con-
sidered it a good candidate for a major MPM-2 epitope kin-
ase. 
The objective of the present study was to test whether the 
deduced MPM-2 epitope sequence motif contains all the in-
formation necessary for recognition and phosphorylation by 
ME kinase-H or another major ME kinase. If so, it could be 
used as an in vitro substrate for purification and functional 
studies of ME kinase-H or to find other potential ME kinases. 
To achieve our goal, we fused two representative MPM-2 
epitope sequences with glutathione S-transferase via gene fu-
sion and determined whether the MPM-2 epitope sequences in 
the fusion protein could be phosphorylated by ME kinase-H 
or another mitotic kinase. 
2. Materials and methods 
2.1. Construction of MPM-2 epitope tagged glutathione S-transferase 
To construct an MPM-2 epitope tagged glutathione S-transferase 
(GST-MPM2), an oligonucleotide encoding DPLTPLQMQKGPLSP-
MKEF was inserted into the BamHI to EcoKl site of pRP259, which 
is a pGEX-1 vector for expression of GST. After transfection into DH 
5a host cell, the expression of GST-MPM2 was induced with 0.4 mM 
isopropyl pi-D-thiogalactopyranoside (IPTG, Boehringer Mannheim, 
Indianapolis, IN) at 37°C for 4 h. GST-MPM2 was purified from 
the cell lysates by affinity chromatography on glutathione agarose 
(Sigma, St. Louis, MO) as previously described [21], except that 0.1 
mM PMSF and 0.1 mg/ml of each leupeptin, pepstatin A, and chy-
mostatin (Boehringer Mannheim) were used as protease inhibitors. 
The washed beads, which contained ~0 .2 iig/ul GST-MPM2, were 
either stored at —20°C directly or eluted with 10 mM glutathione 
containing 0.1 mg/ml of the protease inhibitors described above. 
The eluates, which contained ~ 1 mg/ml GST-MPM2, were stored 
at -20°C until use. 
2.2. Preparation of Xenopus oocyte and egg extracts 
Interphase-arrested Xenopus oocytes extracts were prepared as pre-
viously described [5] except that the oocytes were homogenized in 
extraction buffer XB [22] containing 250 mM NaCl, 5 mM DTT, 
and the protease inhibitors already mentioned. The M-phase arrested 
Xenopus egg extracts were prepared as previously described [23] except 
that the eggs were homogenized in extraction buffer EB [24] contain-
ing 1 mM ATP, 1 uM okadaic acid (OA, LC Services Corporation, 
Woburn, MA), 5 mM DTT, and the same protease inhibitors as 
described above. 
2.3. GST-MPM2 phosphorylation 
To detect GST-MPM2 phosphorylation by MPM-2 immunoblot-
ting, 10 ul of the immobilized GST-MPM2 was mixed with 10 ill of 
kinase sample and 1 ill of a phosphorylation cocktail that gave a final 
concentration of 2 mM ATP, 10 mM NaF, and 0.5 uM OA. After the 
reaction mixture was incubated at 22°C for 30 min, the immobilized 
GST-MPM2 was washed three times with EB containing 0.5 M NaCl, 
1 mM ATP, 5 mM NaF, 2 mM DTT, and 0.5% NP-40, and then 
rinsed once with EB. The eluted proteins were separated by SDS-
PAGE and immunoblotted with MPM-2. For 32P incorporation, the 
phosphorylation reaction mixture contained 10 ul of the immobilized 
GST-MPM2, 10 ul of kinase sample, and 5 ul of labeling cocktail that 
gave a final concentration of 0.5 uCi/ul [y-32P]ATP, 0.5 mM ATP, 10 
mM NaF, and 0.5 uM OA. After incubation of the reaction mixtures 
at 22°C for 30 min, the beads were washed, and the eluted proteins 
were separated by SDS-PAGE. 32P incorporation into GST-MPM2 
was detected by autoradiography. 
2.4. Immunoblotting and immunodepletion 
Immunoblotting was performed as previously described [18]. MPM-
2 ascites for immunoblotting was produced as previously described 
[4], and the anti-rat MAP kinase antibody for immunoblotting was 
obtained from Upstate Biotechnology, Inc. (Lake Placid, NY). For 
MAP kinase immunodepletion, IgG from 30 ul of anti-Xenopus MAP 
kinase immune serum and preimmune serum, which were kindly pro-
vided by Dr. J. Ferrell [25], was immobilized to 50 ul of protein A 
beads, which were then mixed at 4°C for 1.5-3 h with 45-50 ul of the 
samples. After the beads were spun down, the supernatants were 
recovered, and the beads washed three times with EB containing 0.5 
M NaCl, 1 mM ATP, 5 mM NaF, 2 mM DTT, and 0.5% NP-40, and 
once with EB. 
2.5. Chromatography 
All chromatography was performed at 4°C in column buffer (CB), 
which was EB containing 20 mM NaF, 5 mM DTT, 10 uM ATPyS, 
and 0.5 uM OA except when noted otherwise. All ammonium sulfate 
precipitations (40%) were carried out by incubation at 4°C for 30 min 
followed by centrifugation at 35 000x,g- at 4°C for 30 min. For se-
quential chromatography of Xenopus egg extracts, 40 ml of the extract 
was precipitated with 40% ammonium sulfate and then desalted into 
CB containing 1 mM ATPyS. After the desalted sample was incubated 
at 22°C for 2 h for thiophosphorylation to stabilize the mitotic kinases 
[18,23], it was applied to two 5-ml HiTrap Q-Sepharose columns 
(Pharmacia Biotech Inc., Piscataway, NI), which were then washed 
and step eluted with CB containing first 0.2 M NaCl and then 0.4 M 
NaCl. The flowthrough was precipitated with 40% ammonium sulfate 
and further fractionated on two 40-ml Ultrogel AcA34 gel filtration 
columns as described previously [18]. The 0.2 M NaCl eluate was 
precipitated, thiophosphorylated, and applied to a 5-ml Affi-Gel 
blue column (Bio-Rad Laboratories, Hercules, CA), which was then 
washed and eluted with CB containing 0.7 M NaCl. The eluate was 
precipitated and further fractionated by FPLC on a Superose 6 gel 
filtration column. 
2.6. Kinase assays, one-dimensional phosphopeptide mapping, and 
phosphoamino acid analysis 
The in situ ME kinase assay and the assays of histone HI kinase 
activity and MBP phosphorylating activity were performed as previ-
ously described [18]. Phosphoamino acid analysis was performed ac-
cording to Boyle et al [26]. For one-dimensional phosphopeptide map-
ping, 50 ill of immobilized GST-MPM2 was phosphorylated by 100 ul 
of undiluted egg extract in the presence of 1.0 uCi/ul [y-32P]ATP. 
After the beads were washed as described above, the proteins on 
the beads were eluted, separated by 15% SDS-PAGE, and transblot-
ted onto Immobilon-P. This was followed by Coomassie blue staining 
and autoradiography of the proteins on the blot. The top and bottom 
bands of the labeled GST-MPM2 were then sliced off and incubated 
with 1 ug of Glu-C (Boehringer Mannheim) in 50 ul of 50 mM 
NH4HCO3, pH 7.8, at 37°C for 3 h. After the peptides were eluted 
from the membrane by SDS-PAGE sample buffer, they were sepa-
rated by tricine SDS-PAGE [27] followed by autoradiography. 
3. Results 
3.1. Construction of MPM-2 epitope-tagged glutathione 
S-transferase 
We designed a 19-residue peptide DPLTPLQMQKGP-
LSPMKEF containing two representative MPM-2 epitope se-
quences (underlined). LTPLQ is similar to FTPLQ, which 
exhibits a high MPM-2 binding affinity upon phosphoryla-
tion, and LSPMK is similar to LTPLK, which was the 
MPM-2 epitope consensus from screening a phage peptide 
display library [15]. A proline was placed at the N-terminus 
of both LTPLQ and LSPMK for two reasons. First, 7 of the 
19 MPM-2-reactive phage peptides contained a proline at or 
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Fig. 1. Phosphorylation of GST-MPM2 in vitro. (A) Immobilized 
GST or GST-MPM2 was incubated with either control buffer 
(CON), 1:10 diluted IE, or ME at 22°C for 30 min in the presence 
of [y-32P]ATP. Autoradiography of the SDS-PAGE separated pro-
teins is shown. The arrow indicates the position of the labeled GST-
MPM2. (B) Immobilized GST or GST-MPM2 was phosphorylated 
as described for (A) except in the absence of the radiolabeled ATP. 
MPM-2 immunoblotting of the SDS-PAGE separated proteins is 
shown. The arrow indicates the position of the MPM-2-reactive 
GST-MPM2. (C) The 32P-labeled GST-MPM2 was hydrolyzed with 
HCl and subjected to phosphoamino acid analysis. The positions of 
phosphorylated serine (P. SER), threonine (P. THR), and tyrosine 
(P. TYR) are indicated. 
near the amino-terminus of the MPM-2 epitope sequence, 
suggesting that a proline in this position might favor phos-
phorylation or MPM-2 recognition. Second, adding proline at 
this position would generate an overlapping MAP kinase 
phosphorylation site, PX(S/T)P, whose phosphorylation by 
MAP kinase would indicate the availability of the MPM-2 
epitope sequence for phosphorylation. The spacing sequence 
between the two MPM-2 epitope sequences, MQKG, was 
copied from the sequence following LTPLK in the cognate 
MPM-2-reactive peptide selected from the phage peptide li-
brary. Finally, two MPM-2 epitope sequences were placed in 
proximity because 5 of the 19 MPM-2 reactive phage peptides 
contained two MPM-2 epitope sequences and increasing the 
number of the MPM-2 epitope sequences would favor MPM-
2 recognition [15]. 
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For production and purification of the designed peptide 
(MPM-2 peptide), the peptide sequence was attached to the 
carboxy-terminus of recombinant glutathione S-transferase 
(GST) via gene fusion (see Materials and Methods) so that 
it could be easily purified by affinity chromatography on glu-
tathione agarose. This approach had been used successfully by 
Holmes and Solomon to characterize the fine-structure specif-
icity of cyclin-dependent protein kinases [19]. 
To determine whether the MPM-2 peptide in the fusion 
protein, designated GST-MPM2, could be phosphorylated 
specifically by M phase-arrested Xenopus egg extract (ME), 
the immobilized GST or GST-MPM2 was incubated with 
control buffer, 1:10 diluted interphase-arrested Xenopus oo-
cyte extract (IE), or ME in the presence of [y-32P]ATP. Auto-
radiography of the gel-separated proteins showed that while 
GST was not 32P-labeled under any conditions, GST-MPM2 
became 32P-labeled upon incubation with ME but not the 
control buffer or IE (Fig. 1A). This result indicated that at 
least one MPM-2 epitope sequence in the MPM-2 peptide was 
phosphorylated by a kinase that is active only in ME. To 
confirm that phosphorylation of the MPM-2 epitope in 
GST-MPM2 generated MPM-2 reactivity, the phosphorylated 
GST-MPM2 was immunoblotted with MPM-2. Consistent 
with the result from the 32P incorporation experiment, only 
the GST-MPM2 that had been incubated with ME was rec-
ognized by MPM-2 (Fig. IB). This result confirmed that phos-
phorylation of the MPM-2 epitope sequence in GST-MPM2 is 
sufficient for generating MPM-2 immunoreactivity. 
To determine whether one or both of the MPM-2 epitope 
sequences in GST-MPM2 was phosphorylated, GST-MPM2 
that had been 32P-labeled by 1:10 diluted ME was hydrolyzed 
with 6 N HCl at 110°C for 2 h and subjected to phospho-
amino acid analysis. As shown in Fig. 1C, the recovered phos-
phoamino acids contained both phosphoserine and phospho-
threonine. Scintillation counting of each of the phosphoamino 
acids showed that the phosphothreonine was twice as abun-
dant as phosphoserine. However, we later found that during 
phosphoamino acid analysis, phosphothreonine was recovered 
twice as efficiently as phosphoserine. Thus, both MPM-2 epit-
ope sequences were phosphorylated with similar efficiencies. 
If GST-MPM2 was phosphorylated with undiluted ME as 
described above, an additional slower migrating band ap-
peared that was both 32P-labeled and MPM-2 reactive (Fig. 
2A). This suggested that at higher kinase concentration, some 
GST-MPM2 was phosphorylated on both LTPLQ and 
LSPMK, and some on only one of the sequences. To confirm 
this idea, we first treated the phosphorylated GST-MPM2 
with potato acid phosphatase and then separated it by SDS-
PAGE. Phosphatase treatment eliminated the slower migrat-
ing species of GST-MPM2 (Fig. 2B), indicating that the ap-
pearance of the slower migrating molecular species was not 
due to a modification of GST-MPM2 in addition to phos-
phorylation. We next performed a one-dimensional phospho-
peptide mapping of the two bands. A partial digestion of each 
band with Glu-C resulted in a similar collection of phospho-
peptides except that each phosphopeptide from the slower 
migrating band exhibited a slightly higher apparent molecular 
weight than its counterpart from the faster migrating band 
(Fig. 2C). This result indicated that the slower migrating mo-
lecular species was not due to a forced phosphorylation of the 
GST portion of the molecule or a contamination of a labeled 
MPM-2 antigen from the kinase source. We thus concluded 
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Fig. 2. Phosphorylation of GST-MPM2 with different concentrations of Xenopus egg extract. (A) Immobilized GST-MPM2 was phosphorylated 
with either 1:10 diluted ME (lane 1) or the same extract with no dilution (lane 2) at 22°C for 30 min. Top panel: The phosphorylation was 
done in the presence of [y-32P]ATP; autoradiography of the gel-separated proteins is shown. Bottom panel: The phosphorylation was done in 
the absence of radiolabeled ATP; MPM-2 immunoblot of the gel separated proteins is shown. The arrows indicate the positions of the phos-
phorylated GST-MPM2. (B) The immobilized GST-MPM2 that had been phosphorylated with undiluted ME and washed was incubated with 
either control buffer (lane 1) or potato acid phosphatase at 37°C for 2 h before the proteins were separated by SDS-PAGE. Coomassie blue 
staining of gel-separated proteins is shown. (C) After GST-MPM2 was phosphorylated with undiluted ME in the presence of [y-32P]ATP, the 
top (lane 1) and bottom (lane 2) bands of the labeled GST-MPM2 were each digested with Glu-C. The SDS-PAGE separated peptides from 
the digestion are shown. 
that while the faster migrating species of phosphorylated 
G S T - M P M 2 was phosphorylated on either L T P L Q or 
LSPMK, the slower migrating species was phosphorylated 
on both M P M - 2 epitopes. 
Since the slower migrating species of the phosphorylated 
G S T - M P M 2 should contain equal amounts of phosphoserine 
and phosphothreonine, phosphoamino acid analysis of it 
would reveal the relative recovery efficiencies of phosphoser-
ine and phosphothreonine from hydrolysis of the phosphory-
lated G S T - M P M 2 , which would be useful for evaluating 
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Fig. 3. Fractionation of Xenopus egg extracts. (A) ME was precipitated with 40% ammonium sulfate. The starting material (ME), the unprecipi-
tated proteins (SU), and the precipitated proteins (PE) were assayed for their ability to phosphorylate GST-MPM2 by 32P incorporation (top 
panel) or MPM-2 immunoblotting (bottom panel). (B) The thiophosphorylated 40% ammonium sulfate precipitate was fractionated by Q-Se-
pharose chromatography. The starting material (S), flowthrough (FT), 0.2 M NaCl eluate (El), and 0.4 M NaCl eluate (E2) were each assayed 
for their ability to phosphorylate GST-MPM2 by 32P incorporation (top panel) or by MPM-2 immunoblotting (bottom panel). (C) The flow-
through from Q-sepharose chromatography was precipitated by 40% ammonium sulfate and fractionated on a 40-ml UltroGel AcA 34 gel fil-
tration column. The starting material (S) and fractions 12^40 were assayed for ME kinase-H activity by the in situ ME kinase assay (top panel) 
and for mitotic cdc2 kinase activity by histone HI kinase assay (bottom panel). The positions of the standard proteins thyroglobulin (670 kDa) 
and bovine IgG (158 kDa) are indicated. The arrow indicates the phosphorylated histone HI. 
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Fig. 4. MAP kinase accounted for the GST-MPM2 phosphorylating activity. After the 0.2 M NaCl eluate from the Q-sepharose chromatogra-
phy was fractionated by Afn-Gel blue chromatography, the 0.7 M NaCl eluate from it was further fractionated by FPLC on Superose 6 col-
umn. The numbered vertical arrows indicate the positions of the standard proteins: 1, thyroglobulin (670 kDa); 2, bovine IgG (158 kDa); 3, 
chicken ovalbumin (44 kDa); and 4, equine myoglobin (17 kDa). (A) Starting material (S) and fractions 14-44 were assayed for their ability to 
phosphorylate GST-MPM2 by MPM-2 immunoblotting (top panel) or by 32P incorporation (bottom panel). (B) The same samples were immu-
noblotted with anti-MAP kinase antibody (top panel) or assayed for their ability to phosphorylate MBP by 32P incorporation (bottom panel). 
(C) Aliquots of fractions 35-37 from the Superose 6 gel filtration were pooled and immunodepleted by IgG from preimmune serum or from 
anti-Xenopus MAP kinase immune serum bound to protein A beads. After the beads were pelleted, both the supernatants were assayed for 
MBP phosphorylating activity (top panel) and GST-MPM2 phosphorylating activity (bottom panel) by 32P incorporation. Lanes: 1, control 
antibody-absorbed supernatant; 2, anti-MAP kinase-absorbed supernatant; 3, control antibody beads; 4, anti-MAP kinase antibody beads. (D) 
ME was immunodepleted as in (C). The starting material (lane 1), the control antibody-absorbed supernatant (lane 2), and the anti-MAP kin-
ase antibody-absorbed supernatant (lane 3) were assayed for their ability to phosphorylate MBP (top panel) and GST-MPM2 (bottom panel) 
by 32P incorporation. 
whether LTPLQ was more preferentially phosphorylated than 
LSPMK by 1:10 diluted ME. We found that the recovered 
phosphothreonine was approximately twice as abundant as 
the recovered phosphoserine (data not shown), which was 
consistent with the previous finding that phosphothreonine 
was generally more stable than phosphoserine during acid 
hydrolysis [28]. Since this result was similar to that obtained 
from phosphoamino acid analysis of the singly phosphory-
lated GST-MPM2, we concluded that LTPLQ and LSPMK 
were phosphorylated with similar frequencies. 
3.2. The GST-MPM2 phosphorylating activity was not due to 
ME kinase-H or mitotic cdc2 kinase 
To determine whether the MPM-2 epitope sequences in 
GST-MPM2 could be phosphorylated by ME kinase-H or 
other mitotic kinases, we fractionated ME by sequential chro-
matography to separate ME kinase-H, mitotic cdc2 kinase, 
and MAP kinase, any one or all of which might phosphory-
late the MPM-2 epitope sequences in GST-MPM2. The GST-
MPM2 phosphorylating activity was followed at each step by 
both 32P incorporation and MPM-2 immunoblotting. ME was 
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first precipitated with 40% ammonium sulfate to enrich mi-
totic kinases and remove the inhibitor of M phase induction, 
INH, which otherwise might destabilize mitotic kinases [29-
31]. Only the pelleted proteins contained a high GST-MPM2 
phosphorylating activity (Fig. 3A). The thiophosphorylated 
ammonium sulfate precipitate was then fractionated by Q-se-
pharose chromatography. Most GST-MPM2 phosphorylating 
activity was recovered in the 0.2 M eluate, a little in the 
flowthrough, and none in the 0.4 M NaCl eluate (Fig. 3B). 
Since our previous studies showed that mitotic cdc2 kinase 
[32] and most ME kinase-H activity (unpublished data) were 
recovered in the flowthrough and MAP kinase was recovered 
in the 0.2 M NaCl eluate [18], this result suggested that while 
the major MPM2-GST phosphorylating activity in the egg 
extract was not due to ME kinase-H or cdc2 kinase, it might 
be due to MAP kinase. 
To confirm that ME kinase-H activity and mitotic cdc2 
kinase activity were actually recovered from the Q-sepharose 
chromatography, the flowthrough from Q-sepharose chroma-
tography was fractionated by gel filtration on an UltroGel 
AcA 34 column, which is a diagnostic chromatography for 
both ME kinase-H and mitotic cdc2 kinase [18]. An in situ 
ME kinase assay of the collected fractions showed that a peak 
of ME kinase activity was recovered in the 670-kDa fractions 
and generated MPM-2 reactivity on multiple polypeptides 
(Fig. 3C top panel), which is characteristic of ME kinase-H 
activity [18]. A histone HI kinase assay of the fractions 
showed that a strong peak of histone HI kinase activity was 
recovered in the 158-kDa fractions (Fig. 3C bottom panel), 
which did not did not exhibit ME kinase activity in the in situ 
ME kinase assay. This was expected of mitotic cdc2 kinase 
[18]. Recovery of both ME kinase-H and mitotic cdc2 kinase 
activities from the chromatography confirmed that they did 
not contribute significantly to the GST-MPM2 phosphorylat-
ing activity in ME. 
3.3. The GST-MPM2 phosphorylating activity was due to 
MAP kinase 
To test whether the GST-MPM2 phosphorylating activity 
was due to MAP kinase, the 0.2 M eluate from the Q-sephar-
ose chromatography was fractionated by chromatography on 
an Affi-Gel blue column followed by FPLC on a Superose 6 
column. This procedure had been utilized before to purify 
MAP kinase in ME to near homogeneity [18]. In the Affi-
Gel blue chromatography, the GST-MPM2 phosphorylating 
activity was eluted at 0.7 M NaCl (data not shown) like MAP 
kinase [18]. In the Superose 6 gel filtration, the GST-MPM2 
phosphorylating activity peaked in fractions 35-37 (Fig. 
4A), which correlated with both MAP kinase protein, as 
determined by immunoblot, and MAP kinase activity, as 
assayed by phosphorylation of myelin basic protein (MBP, 
Fig. 4B). Moreover, when fractions 35-37 were pooled and 
absorbed with either anti-MAP kinase antibody or control 
antibody affinity beads, the anti-MAP antibody absorption 
removed most of the MBP phosphorylating activity and 
GST-MPM2 phosphorylating activity as compared to the 
control (Fig. 4C). Similar results were also obtained if the 
immunodepletion was done with crude egg extracts (Fig. 
4D). Taken together, these results clearly indicated that 
GST-MPM2 phosphorylating activity in ME was mainly 
due to MAP kinase. 
4. Discussion 
MPM-2 antigens are a distinct family of 50-100 mitotic 
phosphoproteins that contain similar phosphorylated epitopes 
recognized by the monoclonal antibody MPM-2. Although 
the MPM-2 epitope sequences in cellular MPM-2 antigens 
have not been determined, the five-residue peptides FTPLQ 
and LTPLK have been demonstrated to be sufficient for rec-
ognition by MPM-2 upon phosphorylation [15]. This suggests 
that both contain essential structural information for the 
MPM-2 epitope. In the present study, we made a fusion pro-
tein between GST and a 19-residue peptide containing 
LTPLQ, which is very similar to FTPLQ, and LSPMK, which 
is very similar to LTPLK. Using the fusion protein as the 
substrate, we tested whether either or both of the two 
MPM-2 epitope sequences were phosphorylated by ME kin-
ase-H or other mitotic kinases in M phase-arrested Xenopus 
egg extract. We found that while both could be phosphory-
lated by MAP kinase, indicating that they were available for 
phosphorylation, neither was phosphorylated by ME kinase-
H or other mitotic kinases, which suggests that more or differ-
ent structural information than that provided by the minimal 
MPM-2 epitope sequence is required for recognition and 
phosphorylation by the kinase that phosphorylates most 
MPM-2 antigens. 
One possibility to consider is that the MPM-2 epitope se-
quence is only part of the phosphorylation consensus se-
quence. This idea is supported by our experience that when 
we make the substrate blots for the in situ ME kinase assay 
[18], transferring the proteins slowly in the absence of SDS 
but in the presence of methanol is crucial for the MPM-2 
epitope on the substrate blots to be phosphorylated by ME 
kinase-H activity. Since such conditions favor renaturation of 
the SDS-PAGE denatured proteins, this suggests that more 
than a short amino acid sequence is required for recognition 
and phosphorylation by ME kinase-H. An additional require-
ment may involve a distant sequence or a secondary structure. 
It is also possible that the MPM-2 epitope sequences we 
tested were not the type phosphorylated by ME kinase-H. 
Although we assume that the phosphoepitopes recognized 
by the monoclonal antibody MPM-2 possess a common fea-
ture, we cannot exclude the possibility that subtypes of the 
MPM-2 epitope exist that are beyond resolution by MPM-2 
recognition. If such is the case, it is possible that ME kinase-H 
phosphorylates only one subtype of the MPM-2 epitope and 
that his subtype significantly differs from the two MPM-2 
epitope sequences tested in the present study. 
While the inability of mitotic cdc2 kinase to phosphorylate 
LTPLQ, which does not match the phosphorylation consen-
sus sequence for mitotic cdc2 kinase, S/TPXK/R, was ex-
pected, the inability of mitotic cdc2 kinase to phosphorylate 
LSPMK, which matches S/TPXK/R, was at first surprising. 
However, since screening of a synthetic peptide library 
showed that the optimal sequence for cdc2 kinase phospho-
rylation is RRRKSPRK [20], indicating that having basic 
residues both amino-terminal and carboxy-terminal of the 
cdc2 kinase phosphorylation site facilitates cdc2 kinase phos-
phorylation, the possibility should be considered that inclu-
sion of an acidic residue carboxy-terminal of LSPMK in GST-
MPM2 would have greatly hindered its phosphorylation by 
cdc2 kinase. 
The consensus sequence for MAP kinase phosphorylation, 
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PXS/TP, overlaps with the M P M - 2 epitope sequence LT/ 
SPLQ/K. This predicts that if an MPM-2 epitope sequence 
is preceded by a proline, this MPM-2 epitope should be phos-
phorylatable by M A P kinase. We confirmed this prediction by 
showing that both P L T P L Q and P L S P M K in G S T - M P M 2 
were phosphorylated by M A P kinase. It may thus offer a 
valid explanation on why only some of the M A P kinase sub-
strates are M P M - 2 antigens and why M A P kinase phospho-
rylates only a small subset of MPM-2 antigens [18]. Fo r ex-
ample, we showed that , while M A P kinase phosphorylates 
both M B P and MAP2 very well, only MAP2 became 
MPM-2 reactive upon phosphorylation [18]. Consistent with 
the prediction, only the latter protein sequence contains 
M P M - 2 epitope sequences preceded by a proline. Therefore, 
an ideal in vitro substrate specific for MPM-2 epitope kinase 
should be one that only contains MPM-2 epitope sequences 
not proceded by a proline. 
In summary, the findings in the present study suggest that 
while the deduced M PM-2 epitope sequence is sufficient for 
M P M - 2 recognition, it is not equivalent to the phosphoryla-
tion consensus sequence for the MPM-2 epitope kinase. Fur-
ther studies are required to define the relationship between 
them. 
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